# Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

> **NCT00723398** · NA · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 266 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Lovaza 4gm oral
- **DRUG:** Raloxifene 60 Mg Oral Tablet
- **DRUG:** Raloxifene 30 Mg Oral Tablet
- **DRUG:** Lovaza 4gm & Raloxifene 30mg

## Key facts

- **NCT ID:** NCT00723398
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00723398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00723398, "Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00723398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*